Literature DB >> 21403004

Failure of autologous hematopoietic stem cell transplantation to prevent relapse of neuromyelitis optica.

Marcelo Matiello, Sean J Pittock, Luis Porrata, Brian G Weinshenker.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2011        PMID： 21403004     DOI： 10.1001/archneurol.2011.38

Source DB:  PubMed          Journal:  Arch Neurol        ISSN： 0003-9942


× No keyword cloud information.
  15 in total

Review 1.  Neuromyelitis optica spectrum disorders.

Authors:  Eoin P Flanagan; Brian G Weinshenker
Journal:  Curr Neurol Neurosci Rep       Date:  2014-09       Impact factor: 5.081

2.  Late post-transplant anti-aquaporin-4 Ab-positive optic neuritis in a patient with AML.

Authors:  L Diamanti; D Franciotta; G Berzero; P Bini; L M Farina; A A Colombo; M Ceroni; E Marchioni
Journal:  Bone Marrow Transplant       Date:  2015-04-27       Impact factor: 5.483

3.  Autologous nonmyeloablative hematopoietic stem cell transplantation for neuromyelitis optica.

Authors:  Richard K Burt; Roumen Balabanov; Xiaoqiang Han; Carol Burns; Joseph Gastala; Borko Jovanovic; Irene Helenowski; Jiraporn Jitprapaikulsan; James P Fryer; Sean J Pittock
Journal:  Neurology       Date:  2019-10-02       Impact factor: 9.910

4.  Lack of response to monoclonal antibody therapy in neuromyelitis optica.

Authors:  Peiqing Qian; Anne H Cross; Robert T Naismith
Journal:  Arch Neurol       Date:  2011-09

Review 5.  Present and Future Therapies in Neuromyelitis Optica Spectrum Disorders.

Authors:  Ingo Kleiter; Ralf Gold
Journal:  Neurotherapeutics       Date:  2016-01       Impact factor: 7.620

Review 6.  What's new in neuromyelitis optica? A short review for the clinical neurologist.

Authors:  Daniel Whittam; Martin Wilson; Shahd Hamid; Geoff Keir; Maneesh Bhojak; Anu Jacob
Journal:  J Neurol       Date:  2017-03-13       Impact factor: 4.849

7.  Haematopoietic SCT in severe autoimmune diseases: updated guidelines of the European Group for Blood and Marrow Transplantation.

Authors:  J A Snowden; R Saccardi; M Allez; S Ardizzone; R Arnold; R Cervera; C Denton; C Hawkey; M Labopin; G Mancardi; R Martin; J J Moore; J Passweg; C Peters; M Rabusin; M Rovira; J M van Laar; D Farge
Journal:  Bone Marrow Transplant       Date:  2011-10-17       Impact factor: 5.483

8.  Failure of alemtuzumab as a rescue in a NMOSD patient treated with rituximab.

Authors:  Markus C Kowarik; Muna Hoshi; Bernhard Hemmer; Achim Berthele
Journal:  Neurol Neuroimmunol Neuroinflamm       Date:  2016-02-10

Review 9.  Update on the diagnosis and treatment of neuromyelitis optica: recommendations of the Neuromyelitis Optica Study Group (NEMOS).

Authors:  Corinna Trebst; Sven Jarius; Achim Berthele; Friedemann Paul; Sven Schippling; Brigitte Wildemann; Nadja Borisow; Ingo Kleiter; Orhan Aktas; Tania Kümpfel
Journal:  J Neurol       Date:  2013-11-23       Impact factor: 4.849

Review 10.  Th17 Cells Pathways in Multiple Sclerosis and Neuromyelitis Optica Spectrum Disorders: Pathophysiological and Therapeutic Implications.

Authors:  Giordani Rodrigues Dos Passos; Douglas Kazutoshi Sato; Jefferson Becker; Kazuo Fujihara
Journal:  Mediators Inflamm       Date:  2016-01-28       Impact factor: 4.711
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.